指南与共识技术与安全介入CTDSA

预防对比剂后急性肾损伤和超敏反应:英国国家审计

Preventing post-contrast acute kidney injury and hypersensitivity reactions: UK national audit.
PubMed 文献 · Clin Radiol · 2023-08-22

该审计于2022年4月至7月向英国162家NHS服务提供者(涵盖211个放射科)发放问卷,评估其预防碘对比剂不良反应方案对皇家澳大利亚和新西兰放射学家学院2018年碘对比剂指南(获皇家学院认可)的依从性;130个科室回复,结果显示地方方案总体依从性差,肾病风险筛查、肾功能检测应用及超敏反应风险分层、缓解方案与随访记录均不充分。

要点

  • 仅41%的科室对住院患者、56%对门诊患者采用推荐的对比剂后急性肾损伤风险评估。
  • 68%的科室使用建议的阈值考虑肾脏保护,但肾功能检测常被过度使用且结果应用不当。
  • 超敏反应方面,仅9%的科室风险评估正确,36%对已识别高风险患者有正确的风险缓解方案。

核心结论

  • 预防碘对比剂不良反应的地方方案与皇家学院认可的指南基本不一致,各科室需依据当前证据更新方案,以避免医源性并发症或不必要的检查与过度防范。

研究设计与样本

  • 国家审计,向英国所有治疗成人患者且审计负责人注册于皇家学院的急性NHS服务提供者发放问卷(162家提供者,涵盖211个医院放射科),数据收集于2022年4月至7月;61%(129/211)科室回复,代表67%的合格提供者,另有一家独立影像服务提供者补充一组数据(总计n=130)。

诊断标准与关键数值

  • 对比剂后急性肾损伤:41%的回复科室对住院患者、56%对门诊患者有推荐的风险评估。
  • 对比剂后急性肾损伤:68%的回复科室使用建议的阈值考虑肾脏保护。
  • 超敏反应:9%的回复科室风险评估正确,36%对已识别高风险患者有正确的风险缓解方案。

临床应用与阅片要点

  • 作者结论认为地方方案与皇家学院认可的指南基本不一致,科室需按当前证据更新方案以避免医源性并发症或不必要检查与过度防范。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To audit UK radiology departmental protocols related to the prevention of Iodine-based contrast media (ICM) adverse drug reactions (ADRs) and to assess their compliance with the Royal College of Radiologists (RCR) endorsed Royal Australian and New Zealand College of Radiologists' 2018 Iodinated Contrast Guidelines.

MATERIALS AND METHODS: Questionnaires were sent to all UK acute National Health Service (NHS) providers treating adult patients with an audit lead registered with the RCR (162 providers encompassing 211 hospital radiology departments). The questionnaire included three main sections: renal function screening, renal protection regimens, and hypersensitivity reactions prevention and follow-up. Data collection was conducted between April and July 2022.

RESULTS: Sixty-one per cent (129/211) of departments responded, representing 67% of eligible providers. An independent imaging services provider supplied one additional set of data (n=130 overall). Of the responding departments, for post-contrast acute kidney injury (PC-AKI), 41% and 56% had the recommended risk assessment for inpatients and outpatients, respectively. Renal function testing was often over-utilised, and their results were applied improperly. Sixty-eight per cent of departments used the advised threshold for considering renal protection. For hypersensitivity reactions, 9% of departments had the correct risk assessment. Thirty-six per cent of departments had the correct risk mitigation protocol for identified high-risk patients. The documentation and follow-up for hypersensitivity reactions were similarly inadequate.

CONCLUSION: Local protocols on preventing ICM ADRs were largely non-compliant with RCR guidelines. Departments need to update their protocols in line with current evidence to avoid iatrogenic morbidity or unnecessary tests and over-precaution.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Jia Y, Szewczyk-Bieda M, Greenhalgh R, et al. Preventing post-contrast acute kidney injury and hypersensitivity reactions: UK national audit. Clin Radiol. 2023. PMID: 37612224. doi:10.1016/j.crad.2023.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。